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ABSTRACT
OBJECTIVE. The aim of this study was to examine the contribution of a broad range of
external influences to the gut microbiotic composition in early infancy.
METHODS. Fecal samples from 1032 infants at 1 month of age, who were recruited
from the KOALA Birth Cohort Study in the Netherlands, were subjected to
quantitative real-time polymerase chain reaction assays for the enumeration of
bifidobacteria, Escherichia coli, Clostridium difficile, Bacteroides fragilis group, lactoba-
cilli, and total bacterial counts. Information on potential determinants of the gut
microbiotic composition was collected with repeated questionnaires. The associa-
tions between these factors and the selected gut bacteria were analyzed with
univariate and multivariate analyses.
RESULTS. Infants born through cesarean section had lower numbers of bifidobacteria
and Bacteroides, whereas they were more often colonized with C difficile, compared
with vaginally born infants. Exclusively formula-fed infants were more often
colonized with E coli, C difficile, Bacteroides, and lactobacilli, compared with breast-
fed infants. Hospitalization and prematurity were associated with higher preva-
lence and counts of C difficile. Antibiotic use by the infant was associated with
decreased numbers of bifidobacteria and Bacteroides. Infants with older siblings had
slightly higher numbers of bifidobacteria, compared with infants without siblings.
CONCLUSIONS. The most important determinants of the gut microbiotic composition in
infants were the mode of delivery, type of infant feeding, gestational age, infant
hospitalization, and antibiotic use by the infant. Term infants who were born
vaginally at home and were breastfed exclusively seemed to have the most
“beneficial” gut microbiota (highest numbers of bifidobacteria and lowest numbers
of C difficile and E coli).
www.pediatrics.org/cgi/doi/10.1542/
peds.2005-2824
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THE GUT MICROBIOTA plays an important role in hu-man health by providing a barrier for colonization of
pathogens, by exerting important metabolic functions
(fermentation of nondigestible fibers, salvage of energy
as short-chain fatty acids, and production of vitamin K),
and by stimulating the development of the immune
system.1 Bifidobacteria and lactobacilli are considered
the most important health-beneficial bacteria for the
human host, whereas bacteria such as staphylococci and
clostridia are potentially pathogenic.2 Because the gut
microbiota is involved in many aspects of human health,
it is important to understand how the composition of
this microbial ecology is established.
During early life, there are major changes in the
composition of the intestinal microbiota. At birth, the
intestines are sterile. Within a few hours, bacteria start to
appear in the feces. Because the intestinal environment
of neonates shows a positive oxidation/reduction poten-
tial at birth, the gastrointestinal tract is colonized first by
facultative aerobes. Gradually, the consumption of oxy-
gen by these bacteria changes the intestinal environ-
ment into a more-reduced one, permitting the subse-
quent growth of strict anaerobes.3
The bacteria colonizing the infant gut during the first
days of life originate mainly from the mother and the
environment. In early life, one of the first major deter-
minants of the gut microbiota is the mode of delivery.
Vaginally born infants are colonized at first by fecal and
vaginal bacteria of the mother, whereas infants born
through cesarean section are exposed initially to bacteria
originating from the hospital environment and health
care workers.3,4 Other factors that can influence the
composition of the intestinal microbiota in neonates are
the environment during birth, prematurity, hygiene
measures, and the type of infant feeding.5 We showed
previously that breastfed infants had less Clostridium dif-
ficile and Escherichia coli in their feces at the age of 1
month, compared with formula-fed infants, whereas
counts of bifidobacteria were comparable in the 2
groups.6
Although determinants of gut microbiotic composi-
tion were investigated previously in several studies,
those studies focused on only 1 or a few determinants at
a time and generally involved a limited number of in-
fants.7–11 Many potential determinants of the intestinal
microbiota are clustered. For example, infants born
through cesarean section need to stay in the hospital
more often and receive antibiotics more frequently than
do infants born vaginally. Consequently, the effects of
individual determinants on the composition of the in-
testinal microbiota can be distinguished only if a large
population is studied.
The aim of this study was to examine the influence of
a broad range of potential determinants of gut microbi-
otic composition in a prospective cohort study in the
Netherlands. Fecal samples of1000 infants, 1 month of
age, were analyzed with real-time polymerase chain re-
action (PCR) assays, to detect quantitatively several bac-
terial groups and species.
METHODS
Subjects and Study Design
The KOALA Birth Cohort Study is a prospective birth
cohort in the Netherlands. The design of this study was
described in detail elsewhere.12 Briefly, from October
2000 until December 2002, we recruited participants
with diverse lifestyles, at 34 weeks of gestation. Pregnant
women with a conventional lifestyle (N  2343) were
recruited from an ongoing prospective cohort study on
pregnancy-related pelvic girdle pain in the Nether-
lands.13 Pregnant women with an alternative lifestyle (N
 491) were recruited through organic food shops, an-
throposophic doctors and midwives, Steiner schools, and
magazines.
Beginning halfway during recruitment of the cohort
(subjects recruited from January 2002 onward), fecal
samples were collected from infants (N  1176) at the
age of 1 month. Subjects received a feces tube with
spoon (Sarstedt, Nu¨mbrecht, Germany), together with a
sanitary napkin, an instruction form, and a brief ques-
tionnaire (feces questionnaire). Parents collected a fecal
sample by placing a sanitary napkin in the diaper (to
prevent absorption of the feces by the diaper) and col-
lecting the feces out of the napkin into the collection
tube, and they sent the sample as soon as possible (the
same day) to the Department of Medical Microbiology at
the University Hospital of Maastricht, by mail. Exclusion
criteria were insufficient amount of feces (1 g), feces
collected before the age of 3 weeks or after the age of 6
weeks, and missing feces questionnaire.
Information on Potential Determinants
During pregnancy and the first months of the infant’s
life, information on perinatal determinants of the child’s
health, as well as hygiene, infections, nutrition, child
rearing, and other lifestyle characteristics, was collected
for all members of the cohort with repeated question-
naires. On the basis of these questionnaires, the follow-
ing variables were selected as potential determinants of
gut microbiotic composition: maternal education (lower
education, vocational education, higher general second-
ary/preuniversity education, or higher vocational/aca-
demic education); maternal diet, defined as (1) regular
diet (50% of meat, eggs, vegetables, fruit, and milk of
regular origin), (2) vegetarian diet (no meat but other
products mainly of regular origin), (3) organic/biody-
namic diet (50% of meat, eggs, vegetables, fruit, and
milk of organic or biodynamic origin), or (4) organic/
biodynamic vegetarian diet; maternal probiotic use dur-
ing pregnancy (frequency of consumption of dairy prod-
ucts with additional lactic acid-producing bacteria);
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maternal antibiotic use during last month of pregnancy
(yes or no); prolonged rupture of membranes (24 or
24 hours before delivery); place and mode of delivery
(vaginal delivery at home, vaginal delivery in hospital,
artificial delivery [forceps delivery and vacuum extrac-
tion] in hospital, or cesarean section in hospital); hospi-
talization of the infant after birth (days of hospitalization
immediately after birth); infant gender (male or female);
gestational age (37, 37–41, or 41 weeks); birth
weight (2500, 2500–4500, or 4500 g); birth season
(winter, spring, summer, or autumn); type of infant
feeding during the first 1 month of life (exclusively
breastfed, exclusively formula fed, or a combination);
brand of infant formula (exclusive consumption of
brand A, brand B with locust bean gum, brand C, or
brand D with oligosaccharides during the first 1 month
of life); antibiotic/antifungal use by the infant during the
first 1 month of life (yes or no); fever of the infant in the
first 1 month of life (yes or no); number of siblings (0, 1
or 2, or 2); living on a farm (yes or no); and having
furry pets (none, cat, dog, other, or a combination).
DNA Puriﬁcation From Feces
At the laboratory, fecal samples were 10-fold diluted in
peptone/water (Oxoid CM0009) containing 20% (vol/
vol) glycerol (Merck, Darmstadt, Germany) and were
stored at 20°C until analysis. For DNA isolation, 0.2
mL of the diluted feces was added to a 2-mL vial con-
taining 300 mg of glass beads (diameter: 0.1 mm) and
1.4 mL of ASL buffer from the QIAamp DNA stool mini-
kit (Qiagen, Hilden, Germany), and the samples were
disrupted in a mini-bead beater (Biospec Products,
Bartlesville, OK) at 5000 rpm for 3 minutes. Subse-
quently, the bacterial DNA was isolated from the sam-
ples with the QIAamp DNA stool mini kit, according to
the instructions provided by the manufacturer. The DNA
was eluted in a final volume of 200 L.
Microbial Analysis With Real-Time PCR Assays
DNA from all fecal samples was subjected to real-time
PCR assays for bifidobacteria, E coli, C difficile, Bacteroides
fragilis group, lactobacilli, and total bacteria based on 16S
rDNA gene sequences (primers and probes are listed in
Table 1). Development and validation of the real-time
PCR assays were described in detail elsewhere.6,14–17 The
5-nuclease technique was used for detection of bi-
fidobacteria, E coli, C difficile, and members of the B
fragilis group. For detection of bifidobacteria, amplifica-
tions were conducted in a total volume of 50 L, con-
taining 1 TaqMan Universal PCR Master Mix (Applied
Biosystems, Foster City, CA), 300 nmol/L levels of both
primers, 150 nmol/L TaqMan probe, and 20 L of puri-
fied target DNA (see above). For E coli, C difficile, and B
fragilis group, amplifications were conducted in a total
volume of 25 L, containing 1 TaqMan Universal PCR
Master Mix (Applied Biosystems), 900 nmol/L levels of
both primers, 200 nmol/L TaqMan probe, and 10 L of
purified target DNA. The amplification (2 minutes at
50°C, 10 minutes at 95°C, and 42 cycles of 15 seconds at
95°C and 1 minute at 60°C) and detection were con-
ducted with an Applied Biosystems Prism 7000 sequence
detection system (Applied Biosystems).
For quantification of lactobacilli and total bacterial
load, real-time detection of PCR products was conducted
with SYBR Green I (Bio-Rad Laboratories, Hercules,
CA). The PCR for lactobacilli was conducted in a total
volume of 25 L, containing 1 iQ SYBR Green Super-
mix (Bio-Rad), 500 nmol/L levels of both primers, and 5
L of purified target DNA. The amplification was con-
ducted as follows: 5 minutes at 95°C, followed by 35
cycles consisting of 15 seconds at 95°C, 20 seconds at
58°C, and 45 seconds at 72°C, with a final extension step
at 72°C for 5 minutes. After amplification, melting curve
analysis was performed from 60°C to 95°C, with incre-
ments of 0.5°C per 10 seconds. For quantification of the
TABLE 1 Primers and Probes Used in This Study
Target Organisms
(Amplicon Size)
Primer/Probe Sequence (5 to 3) Tm, °C Source
Biﬁdobacterium spp (126 bp) Forward primer GCGTGCTTAACACATGCAAGTC 59 Ref 6
Reverse primer CACCCGTTTCCAGGAGCTATT 59 Ref 6
Probe TCACGCATTACTCACCCGTTCGCC 70 Ref 6
E coli (96 bp) Forward primer CATGCCGCGTGTATGAAGAA 59 Ref 14
Reverse primer CGGGTAACGTCAATGAGCAAA 59 Ref 14
Probe TATTAACTTTACTCCCTTCCTCCCCGCTGAA 68 Ref 14
C difﬁcile (114 bp) Forward primer TTGAGCGATTTACTTCGGTAAAGA 58 Ref 6
Reverse primer TGTACTGGCTCACCTTTGATATTCA 59 Ref 6
Probe CCACGCGTTACTCACCCGTCCG 69 Ref 6
B fragilis group (92 bp) Forward primer CGGAGGATCCGAGCGTTA 58 This study
Reverse primer CCGCAAACTTTCACAACTGACTTA 59 Ref 43
Probe CGCTCCCTTTAAACCCAATAAATCCGG 68 This study
Lactobacillus spp (341 bp) Forward primer AGCAGTAGGGAATCTTCCA 59 Refs 16 and 44
Reverse primer CACCGCTACACATGGAG 59 Refs 16 and 45
Total count (467 bp) Forward primer TCCTACGGGAGGCAGCAGT 59 Ref 17
Reverse primer GGACTACCAGGGTATCTAATCCTGTT 58 Ref 17
Tm indicates melting temperature; bp, base pairs.
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total bacterial load, amplifications were conducted in a
total volume of 25 L, containing 1 iQ SYBR Green
Supermix (Bio-Rad), 300 nmol/L levels of both primers,
and 5 L of purified target DNA. The amplification con-
sisted of 4 minutes at 95°C and 30 seconds at 60°C,
followed by 35 cycles of 30 seconds at 60°C, 15 seconds
at 95°C, and 30 seconds at 60°C. Finally, melting curve
analysis was performed from 60°C to 95°C, with incre-
ments of 0.5°C per 10 seconds. Amplification, melting
curve analysis, and detection were conducted with the
MyiQ single-color, real-time PCR detection system (Bio-
Rad).
Statistical Analyses
Values of log10 colony-forming units (CFU) per gram for
the bacterial groups and species were calculated for each
stool sample from the threshold cycle values by using the
constructed standard curves. The prevalence of coloni-
zation was expressed as the percentage of infants colo-
nized with a specific bacterial group or species. To de-
termine the unadjusted overall effects of the individual
determinants on the prevalence and counts of the bac-
teria simultaneously, the Mann-Whitney rank-sum test
was used.
To analyze the effects of the individual determinants,
with adjustment for all other determinants, 2 multivar-
iate approaches were used. First, linear regression anal-
yses were used to examine the effects of the determi-
nants on the bacterial counts. In the linear regression
analyses, only infants who were colonized with the bac-
terial group or species were included. Total bacterial
count was added as an additional independent variable
to account for differences in the consistency of fecal
samples. Second, logistic regression analyses were used
to examine the effect of the determinants on the prev-
alence of colonization (colonized compared with not
colonized). Both linear and logistic regression models
included all of the determinants under study as indepen-
dent variables and 1 of the bacterial groups or species as
the dependent variable at a time. Length of hospitaliza-
tion (in days) was included as a continuous variable in
the regression models, whereas all other independent
variables were incorporated as categorical variables.
To limit the chance of falsely rejecting the null hy-
pothesis (no association) as a result of multiple testing,
we chose to set  at .01 (2-sided), instead of the usual
.05. Therefore, we present 99% confidence intervals
(CIs) for the odds ratios (ORs) from logistic regression
analyses.
Ethical Considerations
The KOALA Study was approved by the ethics commit-
tee of the University Hospital of Maastricht, and all
parents signed informed consent for the study.
RESULTS
Study Samples
Fecal samples from a total of 1176 infants were collected.
After exclusion of samples that were of insufficient
amount (n  65), samples that were collected before the
age of 3 weeks or after the age of 6 weeks (n  54), and
samples for which the feces questionnaire was missing
(n  25), fecal samples from 1032 infants were included
for analysis.
Almost all infants were colonized with bifidobacteria,
and these bacteria outnumbered all other bacterial
groups and species (Table 2). The majority of infants
were also colonized with E coli and members of the B
fragilis group, whereas both the prevalence and counts of
lactobacilli and C difficile were much lower.
Table 3 shows the prevalence and counts of the bac-
terial groups and species for the individual determinants
under study. In Table 4, the associations between these
determinants and the prevalence and counts of the fecal
bacteria under study, as determined in the multivariate
analyses, are presented. More-detailed information on
these associations, including regression coefficients and
ORs from the linear and logistic regression analyses, is
shown in Table 5.
Maternal Education, Diet, Antibiotic Use, and Probiotic Use
More than one half of the women in this population (n
 572) had a higher vocational or academic degree.
Maternal education was not associated, however, with
the infants’ gut microbiotic composition.
Infants whose mothers consumed an organic or bio-
dynamic diet seemed to have slightly lower numbers of
E coli in their stools than did infants whose mothers
consumed a regular diet (Table 3); however, this associ-
ation was not observed in the multivariate analysis (data
not shown). Mothers who consumed an organic diet
more often (95%) breastfed their infants exclusively,
compared with mothers who consumed a regular diet
(59%), which suggests that the type of infant feeding
was the underlying cause of the association between
maternal diet and infant’s microbiotic composition in the
univariate analysis. Probiotic use and antibiotic use by
TABLE 2 Median Counts and Prevalence of Selected Gut Bacteria in Feces of Infants 1 Month of Age (n 1032)
Biﬁdobacteria E coli C difﬁcile B fragilis Group Lactobacilli Total
Median counts (range), log10 CFU/g feces 10.68 (6.84–11.56) 9.35 (5.91–10.79) 5.32 (2.70–9.57) 9.28 (5.74–10.44) 8.66 (7.92–10.73) 11.12 (9.43–12.14)
Prevalence, % 98.6 87.7 25.0 81.6 32.4 100
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TABLE 3 Median Counts and Prevalence of ColonizationWith Selected Gut Bacteria in Feces of Infants 1 Month of Age (n 1032)
Characteristics No. Biﬁdobacteria E coli C difﬁcile B fragilis Group Lactobacilli Total Counts,
Median, log10
CFU/g Feces
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Maternal education
Lower educationa 75 10.71 100 9.47 92 4.95 24 9.32 77 8.87 39 11.16
Vocational 242 10.73 98 9.43 91 6.37 25 9.41 86 8.65 34 11.18
Higher general
secondary/preuniversity
107 10.68 97 9.41 88 5.49 19 9.29 80 8.66 31 11.06
Higher
vocational/academic
education
572 10.65 99 9.24 86 5.30 25 9.21 80 8.64 30 11.08
Maternal dietb
Regulara 723 10.67 99 9.49 89 5.40 26 9.39 82 8.70 34 11.15
Organic/biodynamic 49 10.56 98 8.91 82c 6.70 16 8.93 75 8.51 33 10.92
Vegetarian 47 10.63 98 9.06 85 6.76 17 9.00 81 8.66 32 11.05
Organic/biodynamic
vegetarian
16 10.61 94 8.66 88 4.17 25 8.16 69 8.48 38 10.91
Maternal probiotic useb
Never/sporadica 814 10.67 99 9.30 88 5.06 25 9.24 82 8.64 32 11.10
Several times per
month
100 10.62 98 9.23 82 6.74 21 9.36 75 8.68 34 11.12
Several times per week 65 10.75 100 9.45 95 5.30 39 9.29 83 8.74 39 11.24
Daily 23 10.48 100 9.71 70 5.40 13 9.34 83 8.71 35 11.21
Maternal antibiotic used
Noa 972 10.68 99 9.32 88 5.10 25 9.28 82 8.65 32 11.12
Yes 38 10.60 92 9.48 95 5.92 16 9.30 74 8.68 50 11.13
Rupture of membranes
24 ha 996 10.67 99 9.36 88 5.30 25 9.28 82 8.68 32 11.12
24 h 36 10.61 100 8.93 89 6.97 19 9.23 78 8.50 31 11.05
Place and mode of
delivery
Natural delivery at
homea
480 10.67 99 9.09 85 4.20 19 9.21 83 8.58 32 11.02
Natural delivery in
hospital
346 10.74 99 9.54 91e 5.45 26c 9.40 85 8.65 34 11.18e
Artiﬁcial delivery in
hospital
76 10.80 100 9.73 91e 6.19 34c 9.60 87 8.50 30 11.36e
Cesarean section in
hospital
108 10.38 96e 9.59 88c 6.36 42e 6.67 63e 8.87 32 11.11
Hospitalization after birth
Noa 737 10.69 99 9.24 87 4.38 20 9.27 83 8.58 32 11.10
1 d 91 10.77 100 9.57 90 6.60 30 9.60 81 8.68 33 11.33c
2–3 d 85 10.65 100 9.72 93e 6.39 40e 9.41 79 8.88 37 11.23
4–6 d 73 10.36 96e 9.76 89 6.03 43e 6.56 68e 8.71 41 11.08
7 d 25 10.25 96c 9.40 88 6.94 40c 8.42 80 9.44 28 10.96
Gender
Malea 531 10.64 99 9.37 89 5.61 24 9.20 80 8.76 32 11.10
Female 501 10.70 98 9.28 86 5.06 25 9.34 83 8.58 33 11.12
Gestational age at birth
37 wk (premature) 11 10.53 91 9.02 73 7.12 64c 8.95 82 8.80 27 10.80
37–41 wka 860 10.68 99 9.30 87 5.06 23 9.27 82 8.61 33 11.12
41 wk (postmature) 37 10.44 100 9.77 84 6.99 35 9.51 78 8.72 32 11.14
Birth weight
2500 g 11 10.45 100 8.67 100 7.12 27 9.31 82 9.12 36 11.28
2500–4500 ga 906 10.67 99 9.32 87 5.08 24 9.30 82 8.65 33 11.12
4500 g 26 10.61 100 9.59 85 6.07 23 9.30 77 8.60 35 11.03
Birth season
Wintera 285 10.67 99 9.37 85 5.61 22 9.20 81 8.65 32 11.11
Spring 241 10.65 96 9.26 88 6.28 25 9.44 82 8.87 37 11.13
Summer 286 10.55 99 9.23 92 4.60 23 9.04 82 8.65 33 11.04
Autumn 216 10.84 99 9.53 86 4.74 30 9.31 81 8.40 26 11.21
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the mother during pregnancy had no influence on the
infant’s gut microbiotic composition.
Delivery and Birth Characteristics
Amniotic membranes ruptured 24 hours before deliv-
ery for only 36 women. We found no association be-
tween prolonged rupture of membranes among women
and the gut microbiotic composition of their infants.
More than one half of the infants were born in the
hospital, and 10% of all infants were born through
cesarean section. In comparison with vaginal delivery at
home, cesarean section resulted in lower colonization
rates and counts of bifidobacteria and B fragilis-group
species, whereas prevalence and counts of C difficile and
counts of E coli were higher. The most-pronounced dif-
ferences in colonization were seen for the B fragilis group
and C difficile; compared with infants born vaginally at
home, the median counts of B fragilis-group bacteria and
C difficile were 100-fold lower and 100-fold higher,
respectively, for infants born through cesarean section
(Table 3). After adjustment for the other determinants,
cesarean section was still associated with lower counts of
bifidobacteria, a lower colonization rate and counts of B
fragilis-group species, and higher counts of C difficile. In
contrast, counts and colonization rate of E coli were no
longer associated with cesarean section in the adjusted
analyses. This is illustrated in Table 5 by a regression
coefficient for counts close to 0 and an OR for prevalence
close to 1.0. Although vaginal delivery and artificial
delivery in the hospital seemed to be associated with
TABLE 3 Continued
Characteristics No. Biﬁdobacteria E coli C difﬁcile B fragilis Group Lactobacilli Total Counts,
Median, log10
CFU/g Feces
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Counts,
Median,
log10
CFU/g
Feces
Prevalence,
%
Type of infant feeding
Exclusively breastfeda 700 10.67 99 9.06 85 4.53 21 8.99 79 8.54 29 10.98
Exclusively formula fed 232 10.69 97 9.84 94e 7.43 33e 9.76 88e 8.93 41e 11.43e
Combination 98 10.78 99 9.76 93e 5.58 35c 9.53 83c 8.71 34 11.36e
Type of infant formula
Brand Aa 47 10.51 96 9.83 91 7.68 40 9.84 89 8.84 34 11.45
Brand B (with locust
bean gum)
19 10.80 95 9.81 89 6.56 21 9.80 95 8.40 47 11.43
Brand C 39 10.81 95 9.82 93 7.28 25 9.70 87 8.68 38 11.28
Brand D (with
oligosaccharides)
20 11.19 100e 9.63 95 6.23 30 10.11 75 9.29 55 11.65
Antibiotic/antimycotic use
during ﬁrst 1 mo
Noa 945 10.70 98 9.32 88 5.50 25 9.31 82 8.65 32 11.12
Oral antibiotic 28 10.29 100c 9.45 79 7.12 18 6.39 82c 8.62 36 10.92
Oral miconazole 22 10.18 100c 9.57 82 4.47 23 9.35 86 8.68 36 11.04
Oral nystatin 15 10.77 93 9.67 87 4.81 13 9.33 73 8.64 33 11.00
Fever in ﬁrst 1 mo
Noa 893 10.67 99 9.31 87 5.07 26 9.25 81 8.61 31 11.11
Yes 47 10.58 100 9.37 87 6.89 11 8.95 81 8.90 38 11.08
Siblings
Nonea 414 10.63 98 9.51 86 6.10 27 9.40 80 8.77 34 11.21
1 452 10.70 99 9.27 88 5.06 23 9.21 82 8.64 31 11.07c
2 165 10.69 100 9.23 90 3.85 25 8.95 82 8.57 33 11.03c
Living on a farm
Noa 979 10.67 99 9.32 87 5.54 25 9.27 81 8.69 32 11.12
Yes 23 10.87 100 9.52 96 4.04 35 9.51 83 8.70 26 11.35
Furry pets
Nonea 552 10.70 98 9.30 89 5.40 27 9.23 83 8.63 32 11.12
Dog 217 10.74 98 9.28 87 4.71 22 9.27 82 8.72 31 11.08
Cat 164 10.62 98 9.57 83 6.57 23 9.39 75 8.73 34 11.15
Other 35 10.71 97 9.19 89 4.88 11 9.29 83 8.23 23 10.94
Combination 64 10.56 100 9.43 94 5.17 28 9.36 83 8.75 41 11.14
Totals may not add up to 1032 because of missing values. Counts were calculated from positive samples only.
a Reference category.
b Consumed during pregnancy.
c P .01, as determined with the Mann-Whitney rank-sum test, calculated from all samples (the statistical signiﬁcance refers to an overall difference incorporating both counts and prevalence).
d Used somewhere during the last month of pregnancy.
e P .001, as determined with the Mann-Whitney rank-sum test, calculated from all samples (the statistical signiﬁcance refers to an overall difference incorporating both counts and prevalence).
516 PENDERS et al
 at Universiteit Maastricht on December 18, 2008 www.pediatrics.orgDownloaded from 
higher counts and prevalences of E coli and C difficile,
compared with home birth (Table 3), these associations
were present only in the unadjusted analyses.
Hospitalization after birth was associated only with a
higher C difficile colonization rate after controlling for
other determinants. The prevalence of C difficile in-
creased13% per day of hospitalization, compared with
nonhospitalized infants (OR: 1.13; 99% CI: 1.01–1.25).
Only 11 infants in this study population were born
premature (37 weeks). These infants were colonized
more often with C difficile (64%, as opposed to 23%),
with considerably higher counts (7.12 log10 CFU/g feces,
compared with 5.06 log10 CFU/g feces), compared with
term infants (Table 3). With adjustment for other deter-
minants, the counts were still statistically significantly
higher (Tables 4 and 5). The OR was still consistent with
a higher colonization rate (OR: 4.47) but was not statis-
tically significant, probably because of the low power
caused by the small number of infants. No association
was found between the gut microbiota and birth weight,
birth season, or gender of the infant.
Infant Feeding
Most infants (n  700) were breastfed exclusively up to
the first 1 month of life, whereas 232 infants were for-
mula fed exclusively and 98 infants received a combina-
tion of breastfeeding and formula feeding. Exclusively
formula-fed infants were more often colonized with E
coli, C difficile, B fragilis group, and lactobacilli than were
their exclusively breastfed counterparts, as shown in
both the unadjusted (Table 3) and adjusted (Tables 4 and
5) analyses. The counts of E coli, C difficile, B fragilis
group, and lactobacilli were also significantly higher for
formula-fed infants, compared with breastfed infants, in
the unadjusted analyses. In the adjusted analyses, only
counts of C difficile were still significantly higher for
formula-fed infants, whereas counts of both E coli (P 
.03) and B fragilis (P  .027) still tended to be higher for
formula-fed infants (not reaching the level of signifi-
cance of P  .01) (Table 5).
In our population, 4 brands of formula were used
frequently. Brand B contained locust bean gum and
brand D was enriched with oligosaccharides, whereas
the others were not. Infants fed exclusively with 1 of
these 4 formulas were compared. As shown in Table 3,
infants fed the oligosaccharide-enriched formula (brand
D) harbored greater numbers of bifidobacteria in their
stools. After adjustment for the other determinants un-
der study, counts of bifidobacteria (coefficient: 0.60; P 
.04) and also counts of lactobacilli (coefficient: 0.75; P 
.02) tended to be higher for infants fed formula D, com-
pared with reference formula A (data not shown).
Antibiotics, Antimycotic Agents, and Fever
Oral use of antibiotics (mainly amoxicillin) by the infant
during the first 1 month of life resulted in decreased
numbers of bifidobacteria and B fragilis-group species.
Lower counts of bifidobacteria were also observed after
oral administration of the antimycotic miconazole (Ta-
bles 3 and 4). Infants who experienced a fever in their
first 1 month of life did not have different gut microbi-
otic composition, compared with infants without a fever.
TABLE 4 Associations Between Determinants and Selected Gut Bacteria in Feces of Infants 1 Month of Age, as Determined in Multivariate
Analyses
Association
Biﬁdobacteria E coli C difﬁcile B fragilis Group Lactobacilli
Counts Prevalence Counts Prevalence Counts Prevalence Counts Prevalence Counts Prevalence
Cesarean section (compared
with vaginal delivery)
 ND   
Hospitalization (d) ND 
Prematurity (compared with
term infants)
ND 
Exclusive formula feeding
(compared with exclusive
breastfeeding)
ND     
Antibiotic use by infant (yes/no)  ND 
Miconazole use by infant (yes/
no)
 ND
Siblings (yes/no)  ND
Results for determinants with no statistically signiﬁcant results for any of the bacteria are not presented. Associations between determinants and counts were examined with linear regression
analyses; models included the following independent variables: maternal education, maternal diet, maternal probiotic use, maternal antibiotic use, rupture of membranes, place and mode of
delivery, gender, gestational age, birth weight, birth season, hospitalization after birth, type of infant feeding, antibiotic/antimycotic use by infant, fever of infant, siblings, farm residence, furry pets,
and total bacterial count. Associations between determinants and prevalence of colonization (colonized compared to not colonized) were examined with logistic regression analyses; models
included the following variables:maternal education,maternal diet,maternal probiotic use,maternal antibiotic use, rupture ofmembranes, place andmodeof delivery, gender, gestational age, birth
weight, birth season, hospitalization after birth, type of infant feeding, antibiotic/antimycotic use by infant, fever of infant, siblings, farm residence, and furry pets. ND indicates not determined
(logistic regression analysis of prevalence of biﬁdobacteria was not performed because 99% of infants were colonized);, positive association, P .01;, positive association, P .001;,
negative association, P .01;, negative association, P .001.
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Home Environment
Infants with older siblings had lower total bacterial
counts per gram of feces than did infants without sib-
lings, as seen in the unadjusted analysis (Table 3). After
adjustment for these differences in total bacterial counts
and other potential differences between infants with and
without siblings, a greater proportion of bifidobacteria
was found for infants with older siblings, compared with
infants without siblings (Tables 4 and 5). Infants’ gut
microbiota was not associated with farm residence or the
presence of furry pets in the home, as determined in
both the unadjusted (Table 3) and multivariate (data not
shown) analyses.
DISCUSSION
To our knowledge, this is the first large, prospective,
epidemiologic study on determinants of gut microbiotic
composition in early infancy. As a consequence of the
large number of infants in the KOALA study, we were
able to study the potential determinants in a multivari-
ate manner and to distinguish their independent effects.
The fecal samples were analyzed with real-time quanti-
tative PCR assays. This molecular approach can be ap-
plied to high-throughput analyses with frozen samples,
which makes this technique very suitable for a large-
scale epidemiologic study such as this. Furthermore,
real-time quantitative PCR analyses overcome many of
the limitations of traditional bacteriologic culture tech-
niques, such as the low sensitivity, the low level of
reproducibility because of the multitude of species to be
identified and quantified, and the time-consuming as-
pects of the conventional methods.14 However, molecu-
lar techniques based on amplification of 16S rDNA re-
quire that the microbial cells in the sample first be lysed
for the extraction of DNA. There is a vast difference in
the susceptibility of the cells of different microbial spe-
cies to lytic procedures. When only 1 lytic method is
used, it is unlikely that template DNA for the real-time
PCR analysis is extracted with equal success from all
species.18 Therefore, we chose to add a mechanical lysis
step to the chemical lyses of the Qiagen stool mini kit.
A drawback of this study was the time between col-
lection of the samples by the parents and processing of
the samples in the laboratory, which was 1 day. Ott et
al19 demonstrated clearly that the total amount of bac-
terial DNA, as well as the diversity of the microbiota,
decreased significantly over such a time period. How-
ever, they also showed that the similarity (determined
with denaturing gradient gel electrophoresis) of fecal
samples processed directly and those processed after 24
hours remained high. This means that the dominant
microbiota seems to be relatively stable. Furthermore,
the aim of the present population-based study was to
examine differences in gut microbiotic composition be-
tween subjects.19 It is not likely that the possible changesT
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in composition of the samples during transport were
influenced by the determinants under study.
It was demonstrated previously that diet can have an
influence on the gut microbiota. For example, introduc-
tion of an extreme vegan diet was shown to change
bacterial fatty acid profiles in the feces.20 Also, an organic
diet (consumption of foods that are produced without
the use of synthetic inputs, such as synthetic fertilizers
and pesticides, veterinary drugs, genetically modified
seeds and breeds, preservatives, additives, and irradia-
tion) may influence the gut microbiota, because organ-
ically produced foods include spontaneously fermented
vegetables containing lactobacilli.21 We hypothesized
that the maternal diet not only might be a determinant
of the mother’s gut microbiota but also might influence
her infant’s gut microbiotic composition. Indeed, mater-
nal diet seemed to have some influence on the off-
spring’s microbiota, as shown in the univariate analysis;
E coli counts were lower and the prevalence and counts
of B fragilis-group species tended to be lower for infants
of mothers consuming organic diets. However, this as-
sociation disappeared completely after adjustment for
other determinants. This can be explained at least in part
by the fact that mothers who consume an organic diet
more often breastfeed their infants, compared with
mothers with regular diets. This emphasizes clearly the
need for multivariate analysis when the effects of deter-
minants of gut microbiotic composition are studied.
We did not find an association between maternal use
of probiotics during pregnancy and the intestinal micro-
biotic composition of the offspring at the age of 1 month.
However, it is not unlikely that transfer of probiotic
bacterial strains from mother to child occurs, especially
when the child is exposed to maternal feces during vag-
inal delivery. Although probiotic bacteria do not colo-
nize permanently the gut of adults,22,23 this might be
different for neonates, who do not yet have an estab-
lished gut microbiota. Indeed, Schultz et al24 confirmed
such a transmission of probiotic strains from mother to
child during birth; although the specific probiotic strain
was present in very low numbers (104–105 CFU/g feces)
for most infants, it persisted at least until the age of 6
months. In the present study, we did not investigate the
presence of specific probiotic strains but focused on the
total numbers of bifidobacteria and lactobacilli. Conse-
quently, a putative small contribution of probiotic bac-
terial strains to the total number of lactobacilli or bi-
fidobacteria would not be noticed. Furthermore, the
pregnant women in our cohort used a wide range of
different probiotic products, including different strains.
This heterogeneity might explain why an association
between probiotic use by the mothers and the gut mi-
crobiotic composition of the infants was not found. Firm
conclusions regarding the effects of changes in the ma-
ternal microbiota itself cannot be made, however, be-
cause we have no data on the impact of maternal diet
and probiotic use on the mother’s own microbiota.
In addition to maternal diet and probiotic use, anti-
biotic use by the mother during the last month of preg-
nancy was selected as a potential determinant of the
infant’s microbiota. This was based on the notion that
changes in maternal microbiota could affect the infant’s
microbiota. However, as for the previous 2 determi-
nants, maternal antibiotic use was not found to be asso-
ciated with any of the examined gut bacteria.
Prolonged rupture of amniotic membranes before de-
livery increases the risk of fetal infection, especially with
group B streptococci.25 However, we found no associa-
tion between prolonged rupture of membranes and the
commensal gut bacteria under study. Because the pres-
ence of streptococci was not examined, we cannot draw
any conclusions about the association between pro-
longed rupture of membranes and the presence of this
specific group of bacteria in the infant’s gut.
The colonization rate and counts of the B fragilis
group differed most markedly between vaginally deliv-
ered infants and infants born through cesarean section.
This is in agreement with 2 previous studies, which also
found levels of members of the B fragilis group to be
greatly reduced as a result of cesarean section.4,26 Fur-
thermore, we found bifidobacterial counts to be lower
(although this was less pronounced) and colonization rates
of C difficile to be higher for infants born through cesarean
section, compared with infants born vaginally at home.
After adjustment for potential confounding by the
other determinants, the hospital environment itself had
an effect only on the colonization rate of C difficile. In-
deed, it is thought generally that infants are being colo-
nized with this spore-forming, anaerobic, microorgan-
ism mainly through the hospital environment. It was
reported previously that vaginal swabs collected just be-
fore delivery were uniformly negative for this organ-
ism.27 In contrast, C difficile was isolated from hands and
stools of healthy hospital personnel and from a NICU,
where spores may persist for months.28 Although car-
riage of C difficile by healthy adults is uncommon,29 the
relatively high colonization rates among asymptomatic
infants found in our study are in accordance with find-
ings from previous studies.30–33 The highest carriage rate
of C difficile in our birth cohort was among premature
infants; 64% of the infants born before 37 weeks of
gestation were colonized. Prematurity is associated
strongly with hospitalization, which could explain in
part the relatively high prevalence of C difficile in preterm
infants. However, after controlling for other determi-
nants, the counts of C difficile were still significantly
higher in preterm infants than in term infants. Several
factors that were not included in the present study may
account for the higher numbers of C difficile in preterm
infants, such as the immature gastrointestinal tract and
delayed oral feeding.
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Like previous studies,11,34,35 we found that breastfed
infants had a microbiota dominated by bifidobacteria,
with rates of colonization with E coli, C difficile, B fragilis-
group species, and lactobacilli that were significantly
lower than those for formula-fed infants. Infants fed
exclusively with a formula supplemented with a mixture
of galactooligosaccharides and fructooligosaccharides
(brand D) had higher counts of bifidobacteria and lacto-
bacilli in their stools, compared with infants fed an un-
supplemented formula. Although the compositions of
the formulas differed not only in the oligosaccharide
supplementation, it is well known that supplementation
with oligosaccharides increases counts of lactic acid-pro-
ducing bacteria.36,37 As opposed to the time of this study,
presently most formulas are supplemented with oligo-
saccharides in the Netherlands; therefore, differences in
gut microbiotic composition as a result of different for-
mulas probably have disappeared.
Although the use of antibiotics may have a major
effect on the composition of the gut microbiota, the
effect differs between antibiotics.38 Because of the small
number of infants in our cohort who received oral an-
tibiotic therapy in their first 1 month, we were not able
to distinguish between different antibiotics. Neverthe-
less, oral antibiotic administration had clear-cut effects
on the anaerobic microbiota, with counts of bifidobac-
teria and Bacteroides being decreased.
In the unadjusted analyses, total bacterial counts
were lower in infants with siblings than in first children.
After adjustment for these differences in total bacterial
counts and all other determinants, the proportion of
bifidobacteria was significantly higher in infants with
older siblings, compared with first children, and counts
of E coli also tended to be higher in infants with older
siblings. Again, this emphasizes the importance of mul-
tivariate analyses in studying a range of determinants of
the gut microbiota. Studies on the etiology of allergic
diseases have often found a protective effect of older
siblings.39 This sibling effect has been hypothesized to be
a marker of early-life infections. However, direct evi-
dence for this hypothesis is lacking.40 Because allergic
diseases have also been linked to aberrant gut microbi-
otic composition,41,42 it has been suggested that this sib-
ling effect in allergy could be partly attributable to the
commensal gut microbiotic composition. To our knowl-
edge, we are the first to demonstrate that having older
siblings is indeed associated with the composition of the
gut microbiota. It is clear, however, that the difference
between children with and without siblings is small, and
the clinical relevance of this difference remains to be
elucidated.
CONCLUSIONS
Infant feeding had a major effect on the gut microbiotic
composition in infants at the age of 1 month. Breastfed
infants were less often colonized with bacteria other
than bifidobacteria, compared with formula-fed infants.
The effect of mode of delivery was also of major impor-
tance, especially regarding Bacteroides. Although passing
through the birth canal (vaginal delivery) and thus com-
ing in contact with maternal feces was associated
strongly with the infant’s gut microbiota, we found no
effect on the infant’s gut microbiota of determinants that
potentially influence the microbial composition of ma-
ternal feces (maternal diet, antibiotic use, and probiotic
use). Hospitalization and prematurity were both associ-
ated positively with C difficile. Antibiotic use reduced
greatly the levels of obligate anaerobes (bifidobacteria
and Bacteroides), whereas having older siblings was asso-
ciated with slightly higher bifidobacterial counts. Term
infants who were born vaginally at home and were
breastfed exclusively seemed to have the most “benefi-
cial” gut microbiota, with the highest numbers of bi-
fidobacteria and lowest numbers of C difficile and E coli.
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